No Data
Prominent Wall Street short sellers: Investors should focus on defensive stocks earnings and wait for clearer employment data.
Morgan Stanley maintains a neutral stance on defensive stocks related to cyclical sectors in the economy, waiting for 'clearer' employment data. The bank believes employment data is a key driving factor for the year-end stock market.
BMO Capital Maintains National Health Investors Inc(NHI.US) With Buy Rating, Raises Target Price to $92
BMO Capital analyst Juan C. Sanabria maintains $National Health Investors Inc(NHI.US)$ with a buy rating, and adjusts the target price from $80 to $92.According to TipRanks data, the analyst has a
National Health Investors (NHI) Is a Great Momentum Stock: Should You Buy?
National Health Investors Analyst Ratings
Deutsche Bank Maintains National Health Investors Inc(NHI.US) With Buy Rating, Raises Target Price to $90
Deutsche Bank analyst Omotayo Okusanya maintains $National Health Investors Inc(NHI.US)$ with a buy rating, and adjusts the target price from $69 to $90.According to TipRanks data, the analyst has a
Deutsche Bank Raises Price Target on National Health Investors to $90 From $69, Keeps Buy Rating